Member neha
Member-
neha posted an update in the group
2 months agoPharma News 2 months agoIndian Firm’s Novel Antibiotic ‘Zaynich’ Gets FDA Nod for Review — A Big Step Against Drug-Resistant Infections
The United States Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Zaynich, a first-in-class antibiotic developed by Wockhardt Ltd., marking a historic milestone — it’s the first time an Indian…
-
neha posted an update in the group
2 months agoPharma News 2 months agoFDA Clears New Gene Therapy for Spinal Muscular Atrophy — Big Hope for Older Children & Adults
A groundbreaking approval: the U.S. FDA has cleared Itvisma, a one-time gene therapy for patients aged 2 years and older with Spinal Muscular Atrophy (SMA), offering a potential lifeline for those previously beyond the reach of existing treatments.
-
neha posted an update in the group
2 months agoPharma News 2 months ago🌟 India’s Home‑grown Antibiotic Breakthrough: A New Hope Against Drug‑Resistant Infections
As a practising physician in India, I’m thrilled by the recent announcement of Nafithromycin — the first antibiotic discovered and developed entirely within India.
For many of us on the front lines, antimicrobial resistance is a growing nightmare: rising…
-
neha posted an update in the group
2 months agoPharma News 2 months agoIndian Regulators Crack Down: Strict GMP Compliance Required by Year End
As a clinician, the latest move from drug regulators raises both concern and hope. The DCGI has issued a final directive: all pharma manufacturing plants must fully comply with updated Good Manufacturing Practice (GMP) rules by 31 December 2025, or face closure.
Why…
-
neha posted an update in the group
2 months agoPharma News 2 months agoIndia’s GST Rate on Medical Devices Cut to 5%
The Indian government has reduced the Goods & Services Tax (GST) on a wide range of medical devices to 5% effective from 22 September 2025.
As a physician, this move signals both opportunity and responsibility:
-
Patient affordability improves – With lower tax, devices such as diagnostics kits,…
-
-
neha posted an update in the group
2 months agoPharma News 2 months agoNovo Nordisk Cuts Price of Wegovy by Up to 37% in India
The Danish drug-maker has reduced the Indian retail price of its obesity treatment Wegovy (semaglutide) by up to 37%, aiming to broaden access as competition in the weight-loss drug category intensifies.👨⚕️ From a Doctor’s Perspective
-
Patient access improvement: Lowering the price means…
-
-
Smart Cold-Chain Tech Lands for Clinics — Take on Vaccine Storage Upgrade
As a practising physician, I’m excited by a new development that directly impacts the front-line of patient care: a team from Blackfrog Technologies in Manipal has launched the EMON-25, an intelligent retrofit system that converts regular medical refrigerators into…
-
neha posted an update in the group
3 months agoPharma News 3 months agoQuality-Check Crackdown: Doctors Alerted as Regulators Clamp Down on Faulty Licences
As a physician, recent regulatory action in India feels like a wake-up call. Senior officials announced that any pharma firm found submitting fake or misleading documents to obtain licences will face immediate bans under new amendments to the Central Drugs…
-
neha posted an update in the group
3 months agoPharma News 3 months agoDigital Roundtables: Redefining Pharma-Physician Engagement
In my daily practice, I’ve noticed how quickly the dynamic between pharmaceutical companies and physicians has shifted—and it’s all moving online. These days, digital roundtables are becoming the primary forum for meaningful engagement.
Instead of crowded conference halls and…
-
neha posted an update in the group
3 months agoPharma News 3 months agoHow Physician Networking Communities Are Reshaping Patient Care
As a practicing doctor, I’ve come to realize that no single clinician can hold all the answers — especially in today’s rapidly evolving medical landscape. That’s where physician networking communities are proving transformative.
Platforms like HealthSocial are not just…
-
neha posted an update in the group
3 months agoPharma News 3 months agoSupreme Court Clears Natco’s Generic Risdiplam: A Win for Patients, a Lesson for Pharma
As a doctor, I see this week’s Supreme Court verdict — allowing Natco Pharma to launch its generic version of Risdiplam — as a landmark moment for both patients and the healthcare ecosystem. Risdiplam is a life-changing drug for Spinal Muscular Atrophy…
-
neha posted an update in the group
3 months agoPharma News 3 months agoIndia’s Pharma Evolution: A Doctor’s Perspective on Progress and Responsibility
As a practising doctor, I see the rapid transformation of India’s pharmaceutical industry not just as industry news, but as something that directly impacts patient care, prescribing habits, and trust in our healthcare system.
Affordability remains a key focus. The…
-
neha posted an update in the group
4 months agoPharma News 4 months agoIndia’s Medical Device Market Poised for Significant Growth by 2033
India’s medical device market is set to expand from USD 6.82 billion in 2025 to approximately USD 12.57 billion by 2034, reflecting a compound annual growth rate (CAGR) of 7.00%. This growth is driven by increased healthcare investment, government support, and…
-
neha posted an update in the group
4 months agoPharma News 4 months agoIndia’s Push for Biosimilars: Affordable Access to Life-Saving Drugs
In oncology and autoimmune care, I often see patients forced to discontinue treatment because the original biologic drug is too expensive. This is where biosimilars — near-identical versions of complex biologics — are changing lives in India.
Recently, Indian pharma…
-
neha posted an update in the group
4 months agoPharma News 4 months agoHow Companion Diagnostics Are Transforming Prescriptions
One change I’ve noticed in recent years is that prescribing is no longer just about choosing a drug — it’s about choosing the right drug for the right patient, backed by a diagnostic test. These are called companion diagnostics, and they’re becoming more common in cancer, infectious…
-
neha posted an update in the group
4 months agoPharma News 4 months agoWhy I Trust Generics — But Double-Check Every Time
In my practice, I prescribe generics frequently. A few months ago, I had a patient with high cholesterol who could not afford a branded statin. I shifted him to a generic version. Within 6 weeks, his LDL had dropped beautifully, and his follow-up labs looked great.
But another patient on a…
-
neha posted an update in the group
4 months agoPharma News 4 months agoAs a doctor, I often see patients asking whether they can combine Ayurvedic medicines with their prescribed allopathic drugs. The interest is understandable — Ayurveda has a rich history of treating chronic illnesses like arthritis, digestive issues, and stress-related disorders through natural formulations, diet, and lifestyle.
Take, for example,…
-
neha posted an update in the group
4 months agoPharma News 4 months agoAs a physician, I often worry when first-line treatments begin to fail — and that’s what’s happening in Pune: Salmonella typhi strains resistant to ceftriaxone have now been documented. Although azithromycin still works for these cases, this trend signals that our antibiotic arsenal is eroding. In practice, this means that empirical therapy for…
-
neha became a registered member 5 months ago
